Effect of Estrogen on Pseudomonas Mucoidy and Exacerbations in Cystic Fibrosis

Chotirmall, Sanjay H.; Smith, Stephen G.; Gunaratnam, Cedric; Cosgrove, Sonya; Dimitrov, Borislav D.; O'Neill, Shane J.; Harvey, Brian J.; Greene, Catherine M.; McElvaney, Noel G.
May 2012
New England Journal of Medicine;5/24/2012, Vol. 366 Issue 21, p1978
Academic Journal
Background: Women with cystic fibrosis are at increased risk for mucoid conversion of Pseudomonas aeruginosa, which contributes to a sexual dichotomy in disease severity. Methods: We evaluated the effects of estradiol and its metabolite estriol on P. aeruginosa in vitro and in vivo and determined the effect of estradiol on disease exacerbations in women with cystic fibrosis. Results: Estradiol and estriol induced alginate production in P. aeruginosa strain 01 and in clinical isolates obtained from patients with and those without cystic fibrosis. After prolonged exposure to estradiol, P. aeruginosa adopted early mucoid morphology, whereas short-term exposure inhibited bacterial catalase activity and increased levels of hydrogen peroxide, which is potentially damaging to DNA. Consequently, a frameshift mutation was identified in mucA, a key regulator of alginate biosynthesis in P. aeruginosa. In vivo levels of estradiol correlated with infective exacerbations in women with cystic fibrosis, with the majority occurring during the follicular phase (P<0.05). A review of the Cystic Fibrosis Registry of Ireland revealed that the use of oral contraceptives was associated with a decreased need for antibiotics. Predominantly nonmucoid P. aeruginosa was isolated from sputum during exacerbations in the luteal phase (low estradiol). Increased proportions of mucoid bacteria were isolated during exacerbations occurring in the follicular phase (high estradiol), with a variable P. aeruginosa phenotype evident in vivo during the course of the menstrual cycle corresponding to fluctuating estradiol levels. Conclusions: Estradiol and estriol induced mucoid conversion of P. aeruginosa in women with cystic fibrosis through a mutation of mucA in vitro and were associated with selectivity for mucoid isolation, increased exacerbations, and mucoid conversion in vivo. (Funded by the Molecular Medicine Ireland Clinician�Scientist Fellowship Programme.)


Related Articles

  • Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosis. McDougal, Kathryn E.; Green, Deanna M.; Vanscoy, Lori L.; Fallin, M. Daniele; Grow, Michael; Cheng, Suzanne; Blackman, Scott M.; Collaco, J. Michael; Henderson, Lindsay B.; Naughton, Kathleen; Cutting, Garry R. // European Journal of Human Genetics;Jun2010, Vol. 18 Issue 6, p680 

    Variants in mannose-binding lectin (MBL2; protein MBL) have shown association with different aspects (eg, lung function, infection, survival) of cystic fibrosis (CF) in some studies but not others. Inconsistent results may be due to confounding among disease variables that were not fully...

  • MUCOIDY AND THE MICROBIOME: COMMUNITY COMPOSITION IN RELATION TO THE PRESENCE OF CULTURABLE, MUCOID PSEUDOMONAS AERUGINOSA. Cox, M. J.; Jones, A. L.; Loebinger, M. R.; Duff, R. M.; Simmonds, N. J.; Davies, J. C.; Wilson, R.; Alton, E. W.; Cookson, W. O. C. M.; Bilton, D.; Moffatt, M. F. // Thorax;Dec2011 Supplement, pA24 

    Introduction and Objectives Cystic fibrosis (CF) and non-cystic fibrosis bronchiectasis (BX) are chronic airway diseases with significant microbial involvement. The presence of mucoid Pseudomonas aeruginosa (mPA) is associated with worse outcomes in these patients. We hypothesised that the...

  • Expression of mucoid induction factor MucE is dependent upon the alternate sigma factor AlgU in Pseudomonas aeruginosa. Yeshi Yin; Heath Damron, F.; Ryan Withers, T.; Pritchett, Christopher L.; Xin Wang; Schurr, Michael J.; Hongwei D. Yu // BMC Microbiology;2013, Vol. 13 Issue 1, p1 

    Background Alginate overproduction in P. aeruginosa, also referred to as mucoidy, is a poor prognostic marker for patients with cystic fibrosis (CF). We previously reported the construction of a unique mucoid strain which overexpresses a small envelope protein MucE leading to activation of the...

  • Investigation of host and pathogen responses to estrogen in cystic fibrosis. Mulla, Moyser; Lavelle, G.; McKiernan, P. J.; Greene, C. M. // BMC Proceedings;2013, Vol. 7 Issue Suppl 1, p1 

    The article presents information on a study conducted on the effect of sex-hormone estrogen (estradiol, E2) on the growth rate of Pseudomonas aeruginosa and the expression of superoxide dismutase (SOD) in Cystic Fibrosis (CF) bronchial epithelial cells. In the study, growth rate of Ps....

  • Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice. Yufa Wang; Cela, Elvis; Gagnon, Stéphane; Sweezey, Neil B. // Respiratory Research;2010, Vol. 11, p166 

    Background: Among patients with cystic fibrosis (CF), females have worse pulmonary function and survival than males, primarily due to chronic lung inflammation and infection with Pseudomonas aeruginosa (P. aeruginosa). A role for gender hormones in the causation of the CF "gender gap" has been...

  • In vitro pharmacodynamic properties of colistin methanesulfonate and amikacin against Pseudomonas aeruginosa. Bozkurt- Guzel, Ç.; Gerceker, A. A. // Indian Journal of Medical Microbiology;Jan2012, Vol. 30 Issue 1, p34 

    Purpose: In vitro pharmacodynamic properties of colistin methanesulfonate and amikacin were investigated by studying time-kill kinetics and post-antibiotic effect (PAE) against strains of Pseudomonas aeruginosa isolated from patients with cystic fibrosis. Method: Synergy was investigated at...

  • Epistatic Roles for Pseudomonas aeruginosa MutS and DinB (DNA Pol IV) in Coping with Reactive Oxygen Species-Induced DNA Damage. Sanders, Laurie H.; Devadoss, Babho; Raja, Geraldine V.; O'Connor, Jaime; Shengchang Su; Wozniak, Daniel J.; Hassett, Daniel J.; Berdis, Anthony J.; Sutton, Mark D. // PLoS ONE;2011, Vol. 6 Issue 4, p1 

    Pseudomonas aeruginosa is especially adept at colonizing the airways of individuals afflicted with the autosomal recessive disease cystic fibrosis (CF). CF patients suffer from chronic airway inflammation, which contributes to lung deterioration. Once established in the airways, P. aeruginosa...

  • Comparisons of resistance of CF and Non-CF pathogens to Hydrogen Peroxide and Hypochlorous Acid Oxidants In Vitro. Bonvillain, Ryan W.; Painter, Richard G; Ledet, Elisa M.; Guoshun Wang // BMC Microbiology;2011, Vol. 11 Issue 1, p112 

    Background: Cystic fibrosis (CF) lung disease has a unique profile of pathogens predominated by Pseudomonas aeruginosa (PsA) and Staphylococcus aureus (SA). These microorganisms must overcome host immune defense to colonize the CF lungs. Polymorphonuclear neutrophils are a major component of the...

  • Cross infection of cystic fibrosis patients with Pseudomonas aeruginosa. Pitt, T.L. // Thorax;Nov2002, Vol. 57 Issue 11, p921 

    Editorial. Focuses on cross infection of cystic fibrosis (CF) patients with Pseudomonas aeruginosa. Mortality rate of CF patients; Choice of antimicrobial compounds; Drug resistance.


Read the Article


Sign out of this library

Other Topics